2H-Isoindole-2-butanoic acid, 4-amino-γ-(aminocarbonyl)-1,3-dihydro-1-oxo- Chemical Properties

Boiling point:

686.7±55.0 °C(Predicted)

Density 

1.467±0.06 g/cm3(Predicted)

solubility 

DMSO (Slightly), Methanol (Slightly)

form 

Solid

pka

4.45±0.10(Predicted)

color 

Off-White to Pale Beige

InChI

InChI=1S/C13H15N3O4/c14-9-3-1-2-7-8(9)6-16(13(7)20)10(12(15)19)4-5-11(17)18/h1-3,10H,4-6,14H2,(H2,15,19)(H,17,18)

InChIKey

USYWQLIFELNXTA-UHFFFAOYSA-N

SMILES

C(N1CC2=C(C=CC=C2C1=O)N)(C(=O)N)CCC(=O)O

2H-Isoindole-2-butanoic acid, 4-amino-γ-(aminocarbonyl)-1,3-dihydro-1-oxo- Usage And Synthesis

Uses

4-(4-Amino-1-oxoisoindolin-2-yl)-4-carbamoyl Butyric Acid is an open impurity of Lenalidomide (L328000), an immunomodulatory drug

2H-Isoindole-2-butanoic acid, 4-amino-γ-(aminocarbonyl)-1,3-dihydro-1-oxo-(2197414-57-4)Related Product Information

• Lenalidomide Impurity 15
• Lenalidomide Impurity 12
• Methyl 2-(chloromethyl)-3-nitrobenzoate
• 2(1H)-Pyrazinone, 4-(cyclohexylcarbonyl)-3,4-dihydro-1-(2-phenylethyl)-
• 3-(5-Amino-1-oxo-isoindolin-2-yl)piperidine-2,6-dione
• Lenalidomide Impurity 16
• 3-amino-N-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1-oxo-1H-isoindol-4-yl]-Propanamide, hydrochloride
• 2,6-Piperidinedione, 3-(1,3-dihydro-5-nitro-1-oxo-2H-isoindol-2-yl)-
• Lenalidomide Impurity 4
• Lenalidomide Impurity 11
• Lenalidomide Impurity 3
• Lenalidomide Impurity 13
• Lenalidomide Impurity 1
• Lenalidomide Impurity 1
• Lenalidomide Impurity 14
• Benzoic acid, 2-(dibromomethyl)-3-nitro-, methyl ester